The U.S. House advances legislation ensuring Medicare coverage for FDA-authorized breakthrough medical technologies, boosting patient access and streamlining approval processes.

Travelers Institute launches a multi-year initiative focused on insurance availability, affordability, and regulatory impacts in the US market. Key events and industry collaboration are planned.

Key September 2025 updates on U.S. healthcare funding, CDC leadership changes, AI in healthcare, Medicare and Medicaid policies, and COVID-19 vaccine authorization shifts impacting insurers and providers.

AdvaMed raises patient safety and legal concerns over CMS's proposed Medicare competitive bidding programme restart for durable medical equipment and devices.

Overview of the 2025 federal healthcare regulatory agenda under the Trump administration, including Medicare rules, ACA integrity measures, and ongoing regulatory reviews impacting healthcare compliance and payer/provider operations.

NAHB advocates for insurance premium reductions for homes built to modern codes and resiliency standards like NGBS Green +RESILIENCE and IBHS FORTIFIED to address rising home insurance costs amid increasing natural disasters.

HHS plans to potentially remove members of the USPSTF, affecting preventive care coverage mandates under the Affordable Care Act and impacting insurance providers and patient access.

Investigative reports reveal healthcare and insurance sector campaign donations shaping state legislative healthcare policies, highlighting impacts on Medicaid and regulatory oversight.

North Carolina regulators approve a moderated 5% average increase in automobile insurance rates for fall 2024, significantly lower than the 23% initially requested by insurers. Key insights into state-level regulatory impact.

Pfizer and other pharmaceutical firms have discussed most-favored-nation drug pricing with the U.S. government, highlighting potential impacts on insurance and payer strategies.